Pembrolizumab is Safe and Active in Platinum- and Cetuximab-Refractory Head and Neck Squamous Cell Carcinoma
2017/3/22
Journal of Clinical Oncology (JCO) Podcast
Frequently requested episodes will be transcribed first
Shownotes Transcript
No transcript made for this episode yet, you may request it for free.